Samsung Biologics Co.,Ltd.

KOSE:A207940 Stock Report

Market Cap: ₩66.5t

Samsung BiologicsLtd Dividends and Buybacks

Dividend criteria checks 0/6

Samsung BiologicsLtd does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.0003%

Buyback Yield

Total Shareholder Yield0.0003%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Samsung Biologics Co.,Ltd. (KRX:207940) Investors Are Less Pessimistic Than Expected

Nov 11
Samsung Biologics Co.,Ltd. (KRX:207940) Investors Are Less Pessimistic Than Expected

These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

Sep 09
These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

Samsung Biologics Co.,Ltd.'s (KRX:207940) 26% Share Price Surge Not Quite Adding Up

Jul 29
Samsung Biologics Co.,Ltd.'s (KRX:207940) 26% Share Price Surge Not Quite Adding Up

Does Samsung BiologicsLtd (KRX:207940) Have A Healthy Balance Sheet?

May 27
Does Samsung BiologicsLtd (KRX:207940) Have A Healthy Balance Sheet?

What Samsung Biologics Co.,Ltd.'s (KRX:207940) P/E Is Not Telling You

Apr 14
What Samsung Biologics Co.,Ltd.'s (KRX:207940) P/E Is Not Telling You

With EPS Growth And More, Samsung BiologicsLtd (KRX:207940) Is Interesting

Mar 01
With EPS Growth And More, Samsung BiologicsLtd (KRX:207940) Is Interesting

These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

Jan 18
These 4 Measures Indicate That Samsung BiologicsLtd (KRX:207940) Is Using Debt Reasonably Well

What Kind Of Shareholders Own Samsung Biologics Co.,Ltd. (KRX:207940)?

Dec 28
What Kind Of Shareholders Own Samsung Biologics Co.,Ltd. (KRX:207940)?

How Much Is Samsung Biologics Co.,Ltd. (KRX:207940) CEO Getting Paid?

Dec 08
How Much Is Samsung Biologics Co.,Ltd. (KRX:207940) CEO Getting Paid?

Did You Miss Samsung BiologicsLtd's (KRX:207940) Impressive 112% Share Price Gain?

Nov 18
Did You Miss Samsung BiologicsLtd's (KRX:207940) Impressive 112% Share Price Gain?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A207940's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A207940's dividend payments have been increasing.


Dividend Yield vs Market

Samsung BiologicsLtd Dividend Yield vs Market
How does A207940 dividend yield compare to the market?
SegmentDividend Yield
Company (A207940)n/a
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.9%
Industry Average (Life Sciences)1.0%
Analyst forecast (A207940) (up to 3 years)0%

Notable Dividend: Unable to evaluate A207940's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A207940's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A207940's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A207940 has not reported any payouts.


Discover strong dividend paying companies